ストックスクリーナーアプリを入手
403.75
0.40%
1.62
アフターアワーズ：
403.75
前日終値:
$402.13
開ける：
$403.05
24時間の取引高:
2.50M
Relative Volume:
1.04
時価総額：
$152.41B
収益：
$42.90B
当期純損益:
$6.52B
株価収益率:
23.68
EPS:
17.05
ネットキャッシュフロー:
$6.72B
1週間 パフォーマンス:
+0.82%
1か月 パフォーマンス:
-5.56%
6か月 パフォーマンス:
-23.77%
1年 パフォーマンス:
-28.83%
1日の値動き範囲:
$401.42
$407.37
1週間の範囲:
$390.66
$407.75
52週間の値動き範囲:
$390.50
$627.88
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
名前
Thermo Fisher Scientific Inc
セクター
電話
(781) 622-1000
住所
168 THIRD AVENUE, WALTHAM, MA
TMO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
403.75 | 151.18B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
190.47 | 134.17B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
515.55 | 40.60B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
113.28 | 31.27B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
141.02 | 23.88B | 15.50B | 1.33B | 2.16B | 7.34 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-10 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | 開始されました | Scotiabank | Sector Perform |
| 2024-10-14 | 開始されました | Redburn Atlantic | Buy |
| 2024-10-01 | 開始されました | Stephens | Overweight |
| 2024-08-28 | 開始されました | Wells Fargo | Overweight |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-03-18 | 再開されました | Citigroup | Neutral |
| 2024-01-24 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2024-01-08 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | 開始されました | HSBC Securities | Buy |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2023-10-26 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | 開始されました | Bernstein | Outperform |
| 2023-09-06 | 再開されました | Citigroup | Buy |
| 2023-07-19 | 開始されました | Raymond James | Outperform |
| 2023-07-19 | 繰り返されました | Robert W. Baird | Outperform |
| 2023-07-13 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | 繰り返されました | Barclays | Overweight |
| 2022-12-14 | 開始されました | Deutsche Bank | Buy |
| 2022-12-07 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-10-27 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2022-08-25 | 開始されました | Credit Suisse | Neutral |
| 2022-04-25 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | 再開されました | Barclays | Overweight |
| 2021-10-20 | アップグレード | Citigroup | Neutral → Buy |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-08-05 | 再開されました | Credit Suisse | Outperform |
| 2021-07-16 | 開始されました | The Benchmark Company | Buy |
| 2021-03-18 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | 開始されました | Barclays | Overweight |
| 2021-01-08 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-12-02 | 開始されました | Goldman | Buy |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | 開始されました | Atlantic Equities | Overweight |
| 2020-09-14 | 開始されました | Morgan Stanley | Overweight |
| 2020-08-20 | 再開されました | JP Morgan | Overweight |
| 2020-07-15 | アップグレード | Cleveland Research | Neutral → Buy |
| 2020-07-07 | 繰り返されました | Needham | Buy |
| 2020-04-23 | 繰り返されました | Needham | Buy |
| 2020-01-31 | 繰り返されました | Needham | Buy |
| 2020-01-22 | 開始されました | Credit Suisse | Neutral |
| 2020-01-08 | 開始されました | Wells Fargo | Equal Weight |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-11-15 | 開始されました | Stifel | Buy |
| 2019-07-25 | 繰り返されました | Needham | Buy |
| 2019-07-16 | ダウングレード | Needham | Strong Buy → Buy |
| 2019-05-30 | 開始されました | Wolfe Research | Outperform |
| 2019-05-23 | 繰り返されました | Needham | Strong Buy |
| 2019-04-22 | 繰り返されました | Needham | Strong Buy |
| 2019-04-16 | 繰り返されました | BofA/Merrill | Buy |
すべてを表示
Thermo Fisher Scientific Inc (TMO) 最新ニュース
Thermo Fisher Must Hand Over Pay Study to Worker Suing for Bias - Bloomberg Law News
Thermo Fisher Scientific launches new Spectral Flow Cytometer - BioSpectrum Asia
Ultra-Low Temperature Freezers Market Is Booming WorldwideThermo Fisher Scientific, PHCbi - openPR.com
Thermo Fisher Scientific Launches New Spectral Flow Cytometer Offering Increased Speed, Versatility and Reliability to Labs - BioSpace
Bioinformatics Market Detailed in New Research ReportThermo Fisher Scientific, Illumina - openPR.com
Lentiviral Vectors Market Set to Witness Increased DemandThermo Fisher Scientific, Merck KGaA - openPR.com
Thermo Fisher Scientific Celebrates Precision Oncology Advancement at ASCO 2025 - BioSpace
Thermo Fisher Scientific Stock: Big Upside Potential After Sluggishness Through November? - Benzinga
Biobank Market Deep Research with Forecast By 2025-2032 | Thermo Fisher Scientific Inc., BioLife Solutions - openPR.com
Agilent Poaches Top Thermo Fisher Executive to Lead Technology Innovation Strategy - Stock Titan
D-Amino Acids Market Report 2025-2030 Featuring Analysis of - GlobeNewswire
Sterilization Monitoring Market Surges Towards USD 1.31 Billion by 2030 Amid Rising Demand for Real-Time Validation - GlobeNewswire Inc.
Spectrometry Market is Booming WorldwideThermo Fisher Scientific, Agilent Technologies - openPR.com
Zacks Investment Ideas feature highlights: Thermo Fisher Scientific and Lululemon - Yahoo Finance
Bioreactors Market Generated Opportunities, Future Scope - openPR.com
Cell-Free DNA Isolation and Extraction Market - GlobeNewswire Inc.
Research Antibodies Market to Witness Remarkable Growth with - openPR.com
Mirai Bio Partners with Thermo Fisher to Integrate AI Design and CGMP Manufacturing for Genetic Medicines - geneonline.com
$1000 Invested In Thermo Fisher Scientific 10 Years Ago Would Be Worth This Much Today - Benzinga
2 S&P 500 Stocks to Buy Now On the Dip for Huge Upside - Yahoo Finance
Thermo Fisher introduces new narcotics analyzers - Wiley Analytical Science
Why Is Thermo Fisher (TMO) Down 6.1% Since Last Earnings Report? - Yahoo Finance
Thermo Fisher makes drug analyzer for law enforcement - The Business Journals
Thermo Fisher Scientific introduces next-generation TruNarc handheld narcotics analyzers - Police1
Cell and Tissue Preservation Market in 2025-2032 Detailed Study - openPR.com
Immune Cell Engineering Market Comprehensive Research Study - openPR.com
Thermo Fisher grants CEO performance-based stock units By Investing.com - Investing.com India
Thermo Fisher grants CEO performance-based stock units - Investing.com
Thermo Fisher Approves CEO’s $60M Stock Award - TipRanks
Thermo Fisher Scientific Grants 5-Year Performance-Based Restricted Stock Units To CEOSEC Filing - marketscreener.com
Thermo Fisher Scientific Inc. (NYSE:TMO) Q1 2025 Earnings Call Transcript - MSN
Thermo Fisher Scientific Introduces Next Generation TruNarc Handheld Narcotics Analyzers to Support Public Safety - BioSpace
Petri Dish: Thermo Fisher’s new partner; Waters buys California company - The Business Journals
Cybin Engages Thermo Fisher Scientific To Provide U.S.-Based Manufacturing for Its CYB003 Program - Technology Networks
Middleton TIF exception created for Thermo Fisher Scientific - MSN
Thermo Fisher Scientific Declares Quarterly DividendMay 21, 2025 - BioSpace
Thermo Fisher Scientific Keeps Quarterly Dividend at $0.43 a Share, Payable July 15 to Investors of Record June 13 - marketscreener.com
Thermo Fisher sets quarterly dividend at $0.43 per share - Investing.com
Thermo Fisher, Mirai Bio link up to advance and produce gene therapies - Fierce Pharma
Mirai Bio announces partnership with Thermo Fisher Scientific - European Pharmaceutical Manufacturer
Middleton approves resolution to support Thermo Fisher Scientific - WKOW
Mirai Bio Announces Strategic Collaboration with Thermo Fisher Scientific - marketscreener.com
Forensics and toxicologyIndustry Focus eBook - News-Medical
Mirai Bio Announces Partnership with Thermo Fisher Scientific to Accelerate Development of Genetic Medicines - PR Newswire
Cybin taps Thermo Fisher for U.S. manufacturing of CYB003 - MSN
Laboratory Clean Bench Market to See Stunning Growth with Esco, Thermo Fisher Scientific, Labconco - openPR.com
Thermo Fisher Scientific launches BSC with improved airflow and ergonomics - Cleanroom Technology
How Thermo Fisher’s KingFisher PlasmidPro crunches hours of plasmid Prep to 5 minutes hands-on - drugdiscoverytrends.com
Thermo Fisher no longer Massachusetts' most valuable company - NBC Boston
Market shift: Boston Scientific emerges as Massachusetts' most valuable public company - The Business Journals
DNA Synthesizer Market Key Players AnalysisThermo Fisher Scientific, Merck KGaA, Agilent Technologies - openPR.com
Thermo Fisher Scientific Inc (TMO) 財務データ
収益
当期純利益
現金流量
EPS
0.77%
大文字化:
|
ボリューム (24 時間):